Skip to main content
Terug
Watch Compare

MAIA Biotechnology, Inc.

Datakwaliteit: 83%
MAIA
NYSE Manufacturing Chemicals
€ 1,42
▲ € 0,05 (3,65%)
6 months return
—
Momentum
Neutral
ROE
-1143,14%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-1143,14%
Onder sectorgemiddelde (-54,47%)
ROIC-492,28%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,18
Interest CoverageN/A

Waardering

PE (TTM|NTM|2027)
-3,20 | 0,47 | 0,44
Onder sectorgemiddelde (-1,49)
P/B Ratio1718,08
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -18,84 M

Price History

Financiële Trends

Koersdoel Analisten

2 analisten
Buy
+754.6%
upside to target
Huidig
€ 1,42
Consensus Target
€ 12,14
€ 10,27
Laag
€ 14,00
Hoog
Vooruitzicht
Forward K/W
0,47
Forward WPA
€ 2,70
Omzet Sch.
66,27 M

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,18 · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,16 -€ 0,17 -€ 0,27 -€ 0,14 — —
Estimate -€ 0,18 -€ 0,25 -€ 0,19 -€ 0,13 -€ 0,18 -€ 0,22
Verrassing +11,11% +32,84% -42,11% -5,23% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -1143,14% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -22,40 M
ROE -1143,14% ROA -196,22%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -18,84 M
ROIC -492,28% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,18
Debt / Equity N/A Current Ratio 1,18
Interest Coverage N/A Asset Turnover N/A
Working Capital 1,76 M Tangible Book Value 41.670

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -3,20 · EV/EBITDA: N/A
P/E Ratio -3,20 Forward P/E 0,47
P/B Ratio 1718,08 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,08 Fwd Earnings Yield 212,77%
FCF Yield -26,32%
Market Cap 71,59 M Enterprise Value 71,59 M

Per Share

EPS: -0,70 · FCF/Share: -0,31
EPS (Diluted TTM) -0,70 Revenue / Share N/A
FCF / Share -0,31 OCF / Share -0,31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 84,14% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 84,14%
SBC-Adj. FCF -21,12 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — 0,0 0,0 0,0
Net Income -22,40 M -23,25 M -19,77 M -15,77 M
EPS (Diluted) -0,70 -1,05 -1,49 -1,75
Gross Profit — — — —
Operating Income -24,27 M -16,96 M -20,18 M -16,18 M
EBITDA — — — —
R&D Expenses 453.745,0 10,01 M 11,11 M 8,93 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — 57,0 6.863,0 6.967,0
Income Tax 2.000,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 9,70 M 10,16 M 7,57 M 12,02 M
Total Liabilities 7,33 M 6,52 M 7,09 M 3,51 M
Shareholders' Equity 2,38 M 3,63 M 477.511,0 8,51 M
Total Debt — — — —
Cash & Equivalents 0,0 0,0 0,0 0,0
Current Assets 9,70 M 10,15 M 7,56 M 11,81 M
Current Liabilities 5,84 M 3,83 M 4,94 M 3,27 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -3,2 -1,5
P/B 1718,1 1,6
ROE % -1143,1 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock
BRSIX BRSIX
0,06% weight